Nasdaq-listed company Silo Pharma makes its first purchase of ETH and SOL
According to ChainCatcher, Nasdaq-listed company Silo Pharma has announced its first purchase under its recently announced cryptocurrency treasury strategy. The company has acquired two cryptocurrencies, ETH and SOL, but the specific purchase amount and quantity have not been disclosed.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Data: If BTC falls below $82,648, the cumulative long liquidation intensity on major CEXs will reach $1.59 billions.
Data: 21.0483 million STRK transferred to a certain exchange, worth approximately $3.14 million
Wormhole Labs launches Sunrise, a standardized liquidity gateway for external assets entering Solana
